UK markets closed

Atara Biotherapeutics, Inc. (ATRA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.6610-0.0307 (-4.44%)
At close: 04:00PM EDT
0.6610 0.00 (0.00%)
After hours: 04:03PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-276,126
-276,126
-228,302
-340,141
-306,620
Depreciation & amortisation
4,829
4,829
5,653
9,345
8,332
Stock-based compensation
45,386
45,386
53,838
53,865
51,351
Change in working capital
15,341
15,341
-61,468
52,584
63,685
Accounts receivable
6,113
6,113
-39,235
264
-1,250
Inventory
-8,120
-8,120
-1,586
0
0
Accounts payable
-3,130
-3,130
-9,211
9,067
-815
Other working capital
-194,200
-194,200
-274,623
-231,102
-185,272
Other non-cash items
16,801
16,801
9,062
2,056
1,665
Net cash provided by operating activities
-192,977
-192,977
-270,430
-220,522
-180,759
Cash flows from investing activities
Investments in property, plant and equipment
-1,223
-1,223
-4,193
-10,580
-4,513
Purchases of investments
-83,648
-83,648
-180,589
-301,129
-425,868
Sales/maturities of investments
208,712
208,712
292,973
333,967
309,653
Net cash used for investing activities
123,866
123,866
202,956
22,258
-120,728
Cash flows from financing activities
Debt repayment
-947
-947
-518
-254
-389
Common stock issued
2,136
2,136
21,891
98,697
422,969
Other financing activities
-107
-107
29,790
-1,261
-1,686
Net cash used provided by (used for) financing activities
2,010
2,010
53,084
103,944
427,574
Net change in cash
-67,101
-67,101
-14,390
-94,320
126,087
Cash at beginning of period
93,088
93,088
107,478
201,798
75,711
Cash at end of period
25,987
25,987
93,088
107,478
201,798
Free cash flow
Operating cash flow
-192,977
-192,977
-270,430
-220,522
-180,759
Capital expenditure
-1,223
-1,223
-4,193
-10,580
-4,513
Free cash flow
-194,200
-194,200
-274,623
-231,102
-185,272